Where does Carmel Pharma AB rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Carmel Pharma AB ranks #13,347 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Carmel Pharma AB hold?

Carmel Pharma AB holds 22 US utility patents granted between 2015 and 2024, spanning 10 technology areas.

What is Carmel Pharma AB's Innovation Score?

Carmel Pharma AB has an Innovation Score of 31.2 out of 100 (37th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Carmel Pharma AB's patent grant rate increasing or decreasing?

Carmel Pharma AB's recent grant velocity is -78% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Carmel Pharma AB's patents?

Carmel Pharma AB's patents average 13.7 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Carmel Pharma AB patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Carmel Pharma AB

Q: What technology areas does Carmel Pharma AB focus on?

Carmel Pharma AB's top technology area is A61J (Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle) with 17 patents, ranking #50 of 903 assignees active in that subclass. Grants appear in 10 CPC subclasses total.

USPTO PatentsView assignee record - 22 granted patents across 10 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61J (Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices ).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Carmel ranks #13,347 of 49,997 tracked US assignees by granted-patent volume, with 22 patents across 10 technology areas.

#13,347
of 49,997 US assignees by volume: 37th percentile
by Innovation Score (31.2/100): 13.7
avg claims per patent: -78%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R13347 · Foreign Corporation #13,347 · 22 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 22 grants
MID-PACK #13,347/49,997
PHOTO-FINISH Canada Pipeline…
CPC-FOCUS A61J · 10 areas
INNOV-THIN 31.2/100
CLAIMS-RICH 13.7 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -78% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Canada Pipeline Accessories Company, Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Carmel’s 31.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.8 pts (35%) Velocity 1.0 pts (3%) Breadth 11.2 pts (36%) Claim depth 8.2 pts (26%)

Qualcomm Incorporated · highest

85
Carmel Pharma AB · this assignee

31
3D Lighting… · lowest

7

What this shows Carmel's Innovation Score is 31.2/100 (37th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Carmel?

Each dot is one of Carmel’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Carmel’s own 13.7 claims/patent is at or below the 16.5 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Carmel vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Carmel's grants concentrate

Carmel Pharma AB is a focused PatentsView assignee: 10 CPC subclasses with 77.3% of grants classified under A61J (Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices ). Peak complete grant year is 2015 (4 grants) versus a trough of 1 in 2021. By volume, Carmel sits between Canada Pipeline Accessories Company, Ltd. and Clariant Plastics & Coatings Ltd.

Carmel's three-year grant acceleration

Carmel Pharma AB shows 1 grants in 2022–2024 against only 7 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Canada Pipeline A…

22
Carbon Black

22
Cardiac Implants

22
Carl Zeiss Vision

22
Celsee Diagnostics

22
Cerevasc

22
Chongqing Ruzer P…

22
Clariant Plastics…

22
Carmel Pharma AB ◀

22

What this shows Carmel holds 22 patents at rank #13,362, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Carmel

By rank, the assignees closest to #13,362 in granted patent volume.

Leaders in A61J (Containers Specially Adapted FOR Medical OR Pharmaceutica…)

Other assignees with the most granted patents in Carmel's primary technology class.

Carmel's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

31 37th percentile higher than 37% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Carmel Pharma AB patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	4	18.2%
2016	3	13.6%
2017	3	13.6%
2018	4	18.2%
2019	4	18.2%
2020	2	9.1%
2021	1	4.5%
2024	1	4.5%

Which technologies does Carmel Pharma AB patent most?

A61J - Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle 17

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 12

B65D - Containers FOR Storage OR Transport OF Articles OR Materials, e.g. Bags, Barrels, Bottles, Boxes, Cans, Cartons, Crates, Drums, Jars, Tanks, Hoppers, Forwarding CONTAINERS; Accessories, Closures, OR Fittings THEREFOR; Packaging ELEMENTS; Packages 7

B65B - Machines, Apparatus OR Devices FOR, OR Methods OF, Packaging Articles OR MATERIALS; Unpacking 5

A61B - DIAGNOSIS; SURGERY; Identification 4

B29L - Indexing Scheme Associated With Subclass B29c, Relating TO Particular Articles 2

B29C - Shaping OR Joining OF PLASTICS; Shaping OF Material IN A Plastic State, NOT Otherwise Provided FOR; After-treatment OF THE Shaped Products, e.g. Repairing 2

B29K - Indexing Scheme Associated With Subclasses B29b, B29c OR B29d, Relating TO Moulding Materials OR TO Materials FOR ; Moulds, ; Reinforcements, Fillers OR Preformed Parts, e.g. Inserts 2

Y10T - Technical Subjects Covered BY Former US Classification 2

F04C - Rotary-piston, OR Oscillating-piston, Positive-displacement Machines FOR Liquids ; Rotary-piston, OR Oscillating-piston, Positive-displacement Pumps 1

Top 10 of 10 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Carmel Pharma AB's patent record in context - here's where to go next.

Carmel Pharma AB's lead technology class is A61J (Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices ), 77.3% of its portfolio - see every assignee active in that class. Explore A61J
Ranked #13,347 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Carmel Pharma AB against Canada Pipeline Accessories Company, Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 31.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.